Isolagen To Host Investor Conference Call To Present An Analysis Of The Data From Phase III Wrinkle Studies

Isolagen(TM), Inc. (Amex: ILE) announced that the Company will host an investor conference call and webcast on Wednesday, October 22 at 4:30 PM Eastern Time to present an analysis of the data from the Isolagen Therapy(TM) Phase III pivotal studies (IT-R-005 and IT-R-006) for the treatment of nasolabial folds, or wrinkles.

More: continued here

Filed under: Dermatology on October 27th, 2008